🇺🇸 FDA
Patent

US 8729047

Compositions for inhibiting redox-sensitive GTPases

granted A61KA61K31/15A61K31/52

Quick answer

US patent 8729047 (Compositions for inhibiting redox-sensitive GTPases) held by The Board of Regents of the University of Texas System expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K31/15, A61K31/52, A61K31/522, A61K33/00